The price-to-earnings (P/E) ratio measures a company’s share price relative to its earnings per share. A high P/E ratio may suggest that a stock is overvalued, with investors paying more for each unit of earnings growth.  Conversely, a lower P/E ratio compared to market averages or industry peers is generally considered advantageous, as it indicates … Continue reading Pharma stocks with low PE ratio to add to your watchlist